Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Hyperpolarization through ATP-sensitive potassium channels; relevance to migraine pathology

    Research output: Contribution to journalLetterResearchpeer-review

  2. Reply: Hyperpolarization through ATP-sensitive potassium channels; relevance to migraine pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The first step towards personalized risk prediction for common epilepsies

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Transcriptome analysis in patients with temporal lobe epilepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Gestational Diabetes Risk in Migrants. A Nationwide, Register-Based Study of all Births in Denmark 2004 to 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. MAIT cell subtypes in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

With the discovery that the highly effective anti-CD20 antibody therapies developed to deplete CD20+ B cells deplete CD20+ T cells equally well, a great interest in the biological properties of CD20+ T cells has emerged. In this study we show that CD20+ T cells have a proinflammatory Th1/Tc1 phenotype with a high proliferative capacity to CNS antigens. We also found that the percentage of CD20+ T cells is increased in the blood of patients with multiple sclerosis and are enriched in the CSF of the patients. Furthermore, we found a positive correlation between CD20+ T cells in the CSF and multiple sclerosis disease severity and see that regulation of CD20+ T cells likely contributes to the positive treatment effect of the multiple sclerosis treatment alemtuzumab. These data represent an important contribution to the understanding of the nature of CD20+ T cells and strongly suggests a role of CD20+ T cells in the pathogenesis of multiple sclerosis.

Original languageEnglish
JournalBrain : a journal of neurology
Volume142
Issue number1
Pages (from-to)120-132
Number of pages13
ISSN0006-8950
DOIs
Publication statusPublished - 1 Jan 2019

    Research areas

  • Adult, Alemtuzumab/therapeutic use, Antigens, CD20/blood, Cell Proliferation/drug effects, Cytokines/metabolism, Female, Flow Cytometry, Humans, Male, Middle Aged, Multiple Sclerosis/blood, Multiple Sclerosis, Chronic Progressive/blood, T-Lymphocytes/drug effects, Young Adult

ID: 57911466